decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 4 (April)
Billing CF Screening
Subscribe or sign in to view the full article.
Article Overview
This article explains how an OB/Gyn billing audience should think about cystic fibrosis screening claims, with emphasis on screening-related diagnosis coding, coverage uncertainty, and the molecular testing procedures commonly associated with the lab work. It is relevant to practices, genetic counselors, and physician-geneticists who need a broad view of the documentation and coding context surrounding CF carrier testing.
Why This Topic Matters
Cystic fibrosis carrier screening can involve multiple billing touchpoints, including diagnosis support, patient financial responsibility, and separate laboratory molecular procedure reporting. Understanding the article helps readers recognize the coding and documentation topics discussed for this type of genetic testing claim.
What You Will Learn
- How cystic fibrosis carrier screening is discussed in the context of billing and reimbursement
- Which broad diagnosis-coding categories are mentioned for supporting CF screening claims
- What general laboratory molecular testing activities are associated with CF testing
- Why coverage uncertainty and patient financial acknowledgment are part of the billing discussion
Who Should Read This
- Ob/Gyn billing staff
- Medical coders
- Genetic counselors
- Physician-geneticists
- Laboratory billing staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com